Live feed02:30:00·27dPRReleasevia QuantisnowDatroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for ImmunotherapyByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
